Popular Articles

ThromboGenics And BioInvent Start Recruitment Of Second 100 Patient Cohort In Phase II DVT Prophylaxis Study With TB-402
ThromboGenics NV (Euronext Brussels: THR) and co-development partner BioInvent International (OMXS: BINV) announce that they have started recruitment of a second cohort of patients for their Phase II trial of TB-402. This follows completion of recruitment of the first cohort of 100 patients ahead of schedule. TB-402 is a novel, long acting anticoagulant that is being developed for the prevention of deep vein thrombosis (DVT) following orthopaedic surgery. The decision to move ahead with the second cohort of this trial follows unanimous advice from the external efficacy and safety monitoring board to proceed using a higher dose of TB-402.

'Artificial Gravity' Can Prevent Muscle Loss In Space
When the Apollo 11 crew got back from the moon, 40 years ago this week, they showed no ill effects from seven days spent in weightlessness. But as American astronauts and Soviet cosmonauts began conducting longer-duration space flights, scientists noticed a disturbing trend: the longer humans stay in zero gravity, the more muscle they lose. Space travelers exposed to weightlessness for a year or more - such as those on a mission to Mars, for example - could wind up crippled on their return to Earth, unable to walk or even sit up.
News of the day
5 Spanish Centers Join A Study For A New Leukemia And Lymphoma Treatment Technique
The Gamida Cell-Teva Joint Venture have today that five prestigious cord blood transplantation centers in Spain, three in Barcelona and two in Valencia, have joined the ExCell study.
Medical Devices

HIV Diagnoses Among Men In New Orleans Growing, Large Increases Reported Among Blacks

HIV diagnoses among all men in Louisiana declined from 1997 to 2006, but increased in 2007 and 2008 - diagnoses in the New Orleans metropolitan area alone increased by 9 percent from 2007 to 2008, according to the Louisiana Office of Public Health, the New Orleans Times Picayune reports. Of particular concern are the increases among black men in New Orleans. Among black men of all ages, new HIV diagnoses increased by 4 percent from 2007 to 2008, but increased 23 percent for black men age 20 to 24 and 30 percent for those age 45 to 54. The reasons behind the findings are "complex," according to the Times Picayune. Risky sexual behavior, a "declining sense of concern among young people about AIDS and the stubborn cultural stigma of homosexuality in the black community are all believed to be factors," the Times Picayune reports (Sandoval-Griffin, New Orleans Times Picayune, 6/27). This information was reprinted from dailyreports.kff.org with kind permission from the Henry J. Kaiser Family Foundation. You can view the entire Kaiser Daily U.S. HIV/AIDS Report, search the archives and sign up for email delivery at dailyreports.kff.org. © Henry J. Kaiser Family Foundation. All rights reserved.


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):